New analysis pipeline for high-throughput domain–peptide affinity experiments improves SH2 interaction data
暂无分享,去创建一个
[1] Gavin MacBeath,et al. A quantitative study of the recruitment potential of all intracellular tyrosine residues on EGFR, FGFR1 and IGF1R. , 2008, Molecular bioSystems.
[2] Ruth Nussinov,et al. Emerging Allosteric Mechanism of EGFR Activation in Physiological and Pathological Contexts , 2019, Biophysical journal.
[3] Kristen M. Naegle,et al. ProteomeScout: a repository and analysis resource for post-translational modifications and proteins , 2014, Nucleic Acids Res..
[4] Joseph J. Falke,et al. [16] Purification of proteins using polyhistidine affinity tags , 2000 .
[5] Ulrich Unnerstall,et al. High Sensitivity Measurement of Transcription Factor-DNA Binding Affinities by Competitive Titration Using Fluorescence Microscopy. , 2019, Journal of visualized experiments : JoVE.
[6] Y. Yarden,et al. Untangling the ErbB signalling network , 2001, Nature Reviews Molecular Cell Biology.
[7] T. Pawson,et al. Assembly of Cell Regulatory Systems Through Protein Interaction Domains , 2003, Science.
[8] G. Stormo,et al. Measuring quantitative effects of methylation on transcription factor–DNA binding affinity , 2017, Science Advances.
[9] Ronald J. Hause,et al. Enhanced Prediction of Src Homology 2 (SH2) Domain Binding Potentials Using a Fluorescence Polarization-derived c-Met, c-Kit, ErbB, and Androgen Receptor Interactome* , 2014, Molecular & Cellular Proteomics.
[10] Livia Perfetto,et al. The protein interaction network mediated by human SH3 domains. , 2012, Biotechnology advances.
[11] Gavin MacBeath,et al. Quantifying protein–protein interactions in high throughput using protein domain microarrays , 2010, Nature Protocols.
[12] T. Pawson,et al. SH2 domains recognize specific phosphopeptide sequences , 1993, Cell.
[13] J. Mackey,et al. PTEN Loss Is Associated with Worse Outcome in HER2-Amplified Breast Cancer Patients but Is Not Associated with Trastuzumab Resistance , 2015, Clinical Cancer Research.
[14] Bissan Al-Lazikani,et al. Large-Scale Profiling of Kinase Dependencies in Cancer Cell Lines , 2016, Cell reports.
[15] Kazuya Machida,et al. The SH2 domain: versatile signaling module and pharmaceutical target. , 2005, Biochimica et biophysica acta.
[16] Qi Zhu,et al. PepCyber:P∼PEP: a database of human protein–protein interactions mediated by phosphoprotein-binding domains , 2007, Nucleic Acids Res..
[17] Marc J. Mazerolle,et al. APPENDIX 1: Making sense out of Akaike's Information Criterion (AIC): its use and interpretation in model selection and inference from ecological data , 2007 .
[18] Richard Anderson-Sprecher,et al. Model Comparisons and R 2 , 1994 .
[19] Andrej-Nikolai Spiess,et al. An evaluation of R2 as an inadequate measure for nonlinear models in pharmacological and biochemical research: a Monte Carlo approach , 2010, BMC pharmacology.
[20] Brett W. Engelmann,et al. SH2 Domains Recognize Contextual Peptide Sequence Information to Determine Selectivity* , 2010, Molecular & Cellular Proteomics.
[21] Matthew S. Creamer,et al. Use of mechanistic models to integrate and analyze multiple proteomic datasets. , 2015, Biophysical journal.
[22] John B. Willett,et al. Another Cautionary Note about R 2: Its Use in Weighted Least-Squares Regression Analysis , 1988 .
[23] A. Gordus,et al. System-wide investigation of ErbB4 reveals 19 sites of Tyr phosphorylation that are unusually selective in their recruitment properties. , 2008, Chemistry & biology.
[24] Marc R Birtwistle,et al. Analytical reduction of combinatorial complexity arising from multiple protein modification sites , 2015, Journal of The Royal Society Interface.
[25] Leonid A. Mirny,et al. Using genome-wide measurements for computational prediction of SH2–peptide interactions , 2009, Nucleic acids research.
[26] Gavin MacBeath,et al. Linear combinations of docking affinities explain quantitative differences in RTK signaling , 2009, Molecular systems biology.
[27] Michele Tinti,et al. The SH2 domain interaction landscape. , 2013, Cell reports.
[28] Gavin MacBeath,et al. A quantitative protein interaction network for the ErbB receptors using protein microarrays , 2006, Nature.
[29] Gavin MacBeath,et al. A multiscale statistical mechanical framework integrates biophysical and genomic data to assemble cancer networks , 2014, Nature Genetics.
[30] Shaw-Pin Miaou,et al. Pitfalls of Using R2 to Evaluate Goodness of Fit of Accident Prediction Models , 1996 .
[31] J. Falke,et al. Purification of proteins using polyhistidine affinity tags. , 2000, Methods in enzymology.
[32] D. O’Connor,et al. High-Throughput Identification of MHC Class I Binding Peptides Using an Ultradense Peptide Array , 2019, The Journal of Immunology.
[33] A. J. Clark,et al. The reaction between acetyl choline and muscle cells , 1926, The Journal of physiology.
[34] Gavin MacBeath,et al. Predicting PDZ domain–peptide interactions from primary sequences , 2008, Nature Biotechnology.
[35] S. Juliano,et al. A Comparison of Methods for Estimating the Functional Response Parameters of the Random Predator Equation , 1987 .
[36] Ronald J. Hause,et al. Comprehensive Binary Interaction Mapping of SH2 Domains via Fluorescence Polarization Reveals Novel Functional Diversification of ErbB Receptors , 2012, PloS one.
[37] T. O. Kvålseth. Cautionary Note about R 2 , 1985 .
[38] Prisca Boisguerin,et al. Quantification of PDZ domain specificity, prediction of ligand affinity and rational design of super-binding peptides. , 2004, Journal of molecular biology.
[39] Ignacio E. Sánchez,et al. Genome-Wide Prediction of SH2 Domain Targets Using Structural Information and the FoldX Algorithm , 2008, PLoS Comput. Biol..
[40] R. Backofen,et al. Semi-Supervised Prediction of SH2-Peptide Interactions from Imbalanced High-Throughput Data , 2013, PloS one.
[41] L. Castagnoli,et al. Protein Interaction Networks by Proteome Peptide Scanning , 2004, PLoS biology.
[42] P. Bork,et al. Linear Motif Atlas for Phosphorylation-Dependent Signaling , 2008, Science Signaling.
[43] M. Moasser,et al. HER2 Amplification in Tumors Activates PI3K/Akt Signaling Independent of HER3. , 2018, Cancer research.
[44] Jordan F Hastings,et al. The Under-Appreciated Promiscuity of the Epidermal Growth Factor Receptor Family , 2016, Front. Cell Dev. Biol..
[45] E. Pol. The importance of correct protein concentration for kinetics and affinity determination in structure-function analysis. , 2010, Journal of visualized experiments : JoVE.
[46] L. Magee,et al. R 2 Measures Based on Wald and Likelihood Ratio Joint Significance Tests , 1990 .
[47] F. White,et al. Src homology 2 domains enhance tyrosine phosphorylation in vivo by protecting binding sites in their target proteins from dephosphorylation , 2017, The Journal of Biological Chemistry.
[48] Gavin MacBeath,et al. Phosphotyrosine Signaling Proteins that Drive Oncogenesis Tend to be Highly Interconnected* , 2013, Molecular & Cellular Proteomics.
[49] Prisca Boisguerin,et al. An improved method for the synthesis of cellulose membrane-bound peptides with free C termini is useful for PDZ domain binding studies. , 2004, Chemistry & biology.
[50] Siew Hong Leong,et al. Chromosomal breaks at FRA18C: association with reduced DOK6 expression, altered oncogenic signaling and increased gastric cancer survival , 2017, npj Precision Oncology.
[51] F. Tian,et al. In silico quantitative prediction of peptides binding affinity to human MHC molecule: an intuitive quantitative structure–activity relationship approach , 2009, Amino Acids.
[52] Tony Pawson,et al. Specificity in Signal Transduction From Phosphotyrosine-SH2 Domain Interactions to Complex Cellular Systems , 2004, Cell.
[53] N. Nagelkerke,et al. A note on a general definition of the coefficient of determination , 1991 .